Financial, market and economic news

Pfizer Canada and BioNTech Initiate Rolling Submission to Health Canada for SARS-CoV-2 Vaccine Candidate BNT162b2

  • Pfizer Canada and BioNTech will continue regular and open dialogue with Health Canada providing results from their ongoing Phase 3 study

KIRKLAND, QC and MAINZ, Germany,…

Read More

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. AcceptRead More

Privacy & Cookies Policy